DUBRF yields 22727.27% · PFE yields 6.13%● Live data
📍 DUBRF pulled ahead of the other in Year 1
Combined, DUBRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DUBRF + PFE for your $10,000?
Dubber Corporation Limited provides unified call recording and voice intelligence cloud solutions worldwide. It offers Dubber You, a tool to search, play, edit, organize, and share conversations from any device; Dubber Teams that capture all conversations for managers and leaders needing central review and control over accurate recordings and data; Dubber Premier, a conversational intelligence tool; Dubber Compliance Editions for compliance teams and managers; and Voice Intelligence Cloud platform. The company also provides Dubber CallN that unified conversational data and recording - automating, analyzing, and distributing insights on customer conversations, agent performance, quality assurance, and others; Dubber Speik that provides secure PCI compliance and call recording; Notes by Dubber, an AI Notetaker that automatically generates transcripts, action items, and rich summaries from calls and meetings; and Dubber PCI for service providers and Amazon Connect. It serves, enterprises, small and medium businesses, financial services, government, education, healthcare, and legal sectors, as well as for service and solution providers. The company was formerly known as Crucible Gold Limited and changed its name to Dubber Corporation Limited in December 2014. Dubber Corporation Limited was incorporated in 1999 and is headquartered in Melbourne, Australia.
Full DUBRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.